Cargando…
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regaden...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873130/ https://www.ncbi.nlm.nih.gov/pubmed/34386859 http://dx.doi.org/10.1007/s12350-021-02731-6 |
_version_ | 1784657397508210688 |
---|---|
author | Kero, Tanja Saraste, Antti Lagerqvist, Bo Sörensen, Jens Pikkarainen, Essi Lubberink, Mark Knuuti, Juhani |
author_facet | Kero, Tanja Saraste, Antti Lagerqvist, Bo Sörensen, Jens Pikkarainen, Essi Lubberink, Mark Knuuti, Juhani |
author_sort | Kero, Tanja |
collection | PubMed |
description | BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regadenoson was compared using correlation and Bland–Altman analysis in 21 patients who underwent rest and adenosine (15)O-water PET scans followed by rest and regadenoson (15)O-water PET scans. RESULTS: Global mean (± SD) MBF values at rest and stress were 0.92 ± 0.27 and 2.68 ± 0.80 mL·g·min for the adenosine study and 0.95 ± 0.29 and 2.76 ± 0.79 mL·g·min for the regadenoson study (P = 0.55 and P = 0.49). The correlations between global and regional adenosine- and regadenoson-based stress MBF were strong (r = 0.80 and r = 0.77). The biases were small for both global and regional MBF comparisons (0.08 and 0.09 mL·min·g), but the limits of agreement were wide for stress MBF. CONCLUSION: The correlation between regadenoson- and adenosine-induced hyperemic MBF was strong but the agreement was only moderate indicating that established cut-off values for (15)0-water PET should be used cautiously if using regadenoson as vasodilator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02731-6. |
format | Online Article Text |
id | pubmed-8873130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88731302022-03-02 Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease Kero, Tanja Saraste, Antti Lagerqvist, Bo Sörensen, Jens Pikkarainen, Essi Lubberink, Mark Knuuti, Juhani J Nucl Cardiol Original Article BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regadenoson was compared using correlation and Bland–Altman analysis in 21 patients who underwent rest and adenosine (15)O-water PET scans followed by rest and regadenoson (15)O-water PET scans. RESULTS: Global mean (± SD) MBF values at rest and stress were 0.92 ± 0.27 and 2.68 ± 0.80 mL·g·min for the adenosine study and 0.95 ± 0.29 and 2.76 ± 0.79 mL·g·min for the regadenoson study (P = 0.55 and P = 0.49). The correlations between global and regional adenosine- and regadenoson-based stress MBF were strong (r = 0.80 and r = 0.77). The biases were small for both global and regional MBF comparisons (0.08 and 0.09 mL·min·g), but the limits of agreement were wide for stress MBF. CONCLUSION: The correlation between regadenoson- and adenosine-induced hyperemic MBF was strong but the agreement was only moderate indicating that established cut-off values for (15)0-water PET should be used cautiously if using regadenoson as vasodilator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02731-6. Springer International Publishing 2021-08-12 2022 /pmc/articles/PMC8873130/ /pubmed/34386859 http://dx.doi.org/10.1007/s12350-021-02731-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Kero, Tanja Saraste, Antti Lagerqvist, Bo Sörensen, Jens Pikkarainen, Essi Lubberink, Mark Knuuti, Juhani Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title | Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title_full | Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title_fullStr | Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title_full_unstemmed | Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title_short | Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
title_sort | quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873130/ https://www.ncbi.nlm.nih.gov/pubmed/34386859 http://dx.doi.org/10.1007/s12350-021-02731-6 |
work_keys_str_mv | AT kerotanja quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT sarasteantti quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT lagerqvistbo quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT sorensenjens quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT pikkarainenessi quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT lubberinkmark quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease AT knuutijuhani quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease |